1Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.The Cardiac Arrhythmia Suppression Trial (CAST) Investigators[J].N Engl J Med,1989,321:406.
2Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.The Cardiac Arrhythmia Suppression Trial Ⅱ Investigators[J].N Engl J Med,1992,327:227.
3Waldo AL, Camm AJ, deRuyter H, et al.Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction.The SWORD Investigators.Survival With Oral d-Sotalol[J].Lancet,1996,348(9019):7.
4Julian DG, Camm AJ, Frangin G, et al.Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT.European Myocardial Infarct Amiodarone Trial Investigators[J].Lancet,1997,349(9053):667.
5Wang Q, Shen J, Splawski I, et al.SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome[J].Cell,1995,80(5):805.
6Keating MT, Sanguinetti MC.Molecular and cellular mechanisms of cardiac arrhythmias[J].Cell,2001,104(4):569.
7Brugada J, Brugada R, Brugada P.Channelopathies: a new category of diseases causing sudden death[J].Herz,2007,32(3):185.
8Brugada R, Hong K, Dumaine R, et al.Sudden death associated with short-QT syndrome linked to mutations in HERG[J].Circulation,2004;109:151.
9Priori SG, Pandit SV, Rivolta I, et al.A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene[J].Circ Res,2005,96(7):800.
10Priori SG, Napolitano C, Tiso N, et al.Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia[J].Circulation,2001,103:196.
